Takeda Pharmaceutical Company Limited
SCREENING METHOD

Last updated:

Abstract:

The present invention provides a useful and efficient screening method for finding a cholinergic muscarinic M1 receptor positive allosteric modulator (M1PAM) with reduced cholinergic side effects. The present invention also provides a method for treating Alzheimer's disease and the like, a method for reducing cholinergic side effects, and the like which use M1PAM selected by the screening method and having a low .alpha. value, or the M1PAM and an acetylcholinesterase inhibitor.

Status:
Application
Type:

Utility

Filling date:

17 May 2018

Issue date:

11 Jun 2020